[1]Patent:US2009/270359,2009,A1.Locationinpatent:Page/Pagecolumn33-34
[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2009/270359,2009,A1Locationinpatent:Page/Pagecolumn34
1003846-21-6
1217501-15-9
2377587-58-9
2096334-37-9
374064-01-4 | 5-Pyridin-3-yl-1H-pyrazole-3-carboxylic acid | AA0079T8 | MFCD05170031
109632-08-8 | 1-(Ethylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol | AA007AC9 | MFCD11549256
109274-92-2 | Furo[2,3-b]pyridine-2-carbaldehyde | AA007AYV | MFCD18384579
1111237-76-3 | 5-Bromo-4-chloro-2-methyl-7h-pyrrolo[2,3-d]pyrimidine | AA007BEZ | MFCD16249868
110821-39-1 | ETHYL 5-BROMO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE | AA007C00 | MFCD03791223
108409-83-2 | β-Catenin/Tcf Inhibitor, FH535 | AA007CLR | MFCD01212888
1104455-41-5 | Methyl 4-chloro-5-methylpicolinate | AA007D4Y | MFCD16987786
1101136-50-8 | 4-[(1-oxo-7-phenylheptyl)amino]-(4R)-octanoic acid | AA007DTJ | MFCD18382098
109963-61-3 | 4-(4-Methoxycarbonylphenyl)benzoic acid | AA007EBT | MFCD00723703
345264-61-1 | 5-Fluoro-1,2,3,4-tetrahydroquinoline | AA007EV8 | MFCD09026770